Stronger. Safer. Better.
Fiscal Year 2020 was unlike any other. But cancer doesn't stop for a pandemic, and neither did MD Anderson. In this annual report, learn how our team, 22,000-strong, responded to COVID-19 – and discover the silver linings that helped us emerge from this year stronger, safer and better.Read what has changed in a year
Collaboration propels research forward
COVID-19 has presented unprecedented challenges for cancer researchers. But new ways of collaborating and harnessing data have yielded new opportunities.
Virtual bedtime stories enchant childhood cancer patients
Before the pandemic, a steady stream of our youngest patients would visit Laura Rodriguez in our K-12 classroom, where she was always ready with a story. Now, she's found a new way to bring them comfort and laughs.
Taking safety in-house
With one of the world's largest populations of immunocompromised patients, MD Anderson couldn't hold out for a national COVID-19 testing strategy or rely on limited supplies of disinfectants and personal protective equipment. Instead, we innovated to ensure the health and safety of our cancer patients and our workforce.Find out how
FY20: The year in review
Virtual programs bring new connections
Thanks to MD Anderson's virtual support programs, patients like Jenn Meyers are finding the support and friendships they need to navigate cancer treatment during the pandemic.
Training and education reimagined
While our educators had to get creative and adapt quickly when the coronavirus pandemic arrived, they didn't waver in their dedication to setting our trainees up for success.
Virtual visits' silver linings
MD Anderson first offered virtual visits to prevent the spread of the coronavirus on our campuses. But as patients, their families and care teams are discovering, telemedicine also enhances cancer care.